EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia

• Hidemasa Matsuo,
• Mio Kajihara,
• Daisuke Tomizawa,
• Tomoyuki Watanabe,
• Akiko Moriya Saito,
• Junichiro Fujimoto,
• Keizo Horibe,
• Kumi Kodama,
• Mayu Tokumasu,
• Hiroshi Itoh,
• Hideki Nakayama,
• Akitoshi Kinoshita,
• Takashi Taga,
• Akio Tawa,
• Tomohiko Taki,
• Norio Shiba,
• Kentaro Ohki,
• Yasuhide Hayashi,
• Yuka Yamashita,
• Akira Shimada,
• Shiro Tanaka,
• Souichi Adachi

Affiliations

Hidemasa Matsuo

Department of Human Health Sciences, Kyoto University, Japan

Mio Kajihara

Department of Human Health Sciences, Kyoto University, Japan

Daisuke Tomizawa

Department of Pediatrics, Tokyo Medical and Dental University (TMDU), Japan

Tomoyuki Watanabe

Department of Nutritional Science, Aichi Gakuin University, Nisshin, Japan

Akiko Moriya Saito

Clinical Research Center, National Hospital Organization Nagoya Medical Center, Japan

Junichiro Fujimoto

Epidemiology and Clinical Research Center for Children’s Cancer, National Center for Child Health and Development, Tokyo, Japan

Keizo Horibe

Clinical Research Center, National Hospital Organization Nagoya Medical Center, Japan

Kumi Kodama

Department of Human Health Sciences, Kyoto University, Japan

Mayu Tokumasu

Department of Pediatrics, Kyoto University, Japan

Hiroshi Itoh

Department of Human Health Sciences, Kyoto University, Japan

Hideki Nakayama

Department of Pediatrics, National Hospital Organization Fukuoka-Higashi Medical Center, Koga, Japan

Akitoshi Kinoshita

Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Japan

Takashi Taga

Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan

Akio Tawa

Department of Pediatrics, National Hospital Organization Osaka National Hospital, Japan

Tomohiko Taki

Department of Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine, Japan

Norio Shiba

Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan

Kentaro Ohki

Department of Hematology and Oncology, Gunma Children’s Medical Center, Shibukawa, Japan

Yasuhide Hayashi

Department of Hematology and Oncology, Gunma Children’s Medical Center, Shibukawa, Japan

Yuka Yamashita

Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Japan

Akira Shimada

Department of Pediatrics, Okayama University Hospitaland, Japan

Shiro Tanaka

Department of Pharmacoepidemiology, Kyoto University, Japan

Souichi Adachi

Department of Human Health Sciences, Kyoto University, Japan